Andere talen Xcelerate Inc.

Aandelen

XCRT

US98401T1051

Beurs gesloten - OTC Markets Andere beurzen 19:32:05 16-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,034 ^USD	-0,18%		-10,53%	-5,56%

29/04	Xcelerate Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
2023	Xcelerate Inc. heeft een beursgang aangevraagd voor een bedrag van $17,25 miljoen.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Xcelerate, Inc. Announces That It Has Filed Its 2023 Annual Report	01/05
Xcelerate Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/04
Xcelerate, Inc. Engages Leading Investor Relations Firm Darrow Associates to Enhance Capital Markets Presence	26/03
Xcelerate, Inc. Announces Participation in The Microcap Conference	19/01
Xcelerate Inc. has filed an IPO in the amount of $17.25 million.	13/11
Xcelerate Inc. Announces Publication of Its Two Utility Patent Applications	24-10-23
Xcelerate Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	22-09-23
Xcelerate Announces Marketing Agreement with ProductSector, LLC	08-08-23
Xcelerate, Inc. Acquires a Majority Interest in ESN Group	26-07-23
Xcelerate Inc. acquired a 51% stake in California Skin Research, Inc. from subscribing for shares and purchasing shares from two of the former principals.	24-07-23
Xcelerate Inc. completed the acquisition of an unknown majority stake in ESN Group, Inc.	20-07-23
Xcelerate Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	28-04-23
Xcelerate Inc. Auditor Raises 'Going Concern' Doubt	28-04-23
Xcelerate, Inc. Announces That Fabian Urquijo Has Accepted an Invitation to Join Its Xcelerate Brands Advisory Board	01-02-23
Xcelerate Inc. entered into a letter of intent to acquire an unknown majority stake in ESN Group, Inc.	17-01-23
Tenet Announces Partnership with Xcelerate Auto to Offer New Warranty Options	28-09-22
Xcelerate Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15-09-22
Xcelerate : Announces Uplisting to OTCQB Market	01-08-22
Xcelerate : OTCQB Certification	20-07-22
Wilken, O’Shea Talk Acquisition of HS Pharmaceuticals and What It Means for The Future Of XCRT	23-05-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Xcelerate Inc.

Aandelen

XCRT

US98401T1051

Andere talen

Filters